Glowing puzzle piece fitting into puzzle
Biotech

Boehringer slots synthetic lethal program into oncology pipeline

Boehringer has partnered with Tessellate Bio on a synthetic lethal program in a deal worth more than 500 million euros in biobucks.
Nick Paul Taylor Apr 23, 2025 7:45am
obesity drugs

Ascletis sees no benefit to high, fast oral GLP-1 dose titration

Apr 23, 2025 7:25am
Fortreas Gani Chico Talks Oncology Innovation AI and Clinical Trial Strategy

Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy

Apr 21, 2025 8:00am
GPS navigation to pins and multiple markers on route

Genentech builds autoimmune Repertoire with $765M deal

Apr 23, 2025 7:00am
Sanofi

Sanofi hands cancer drug to Innate as it pivots R&D pact focus

Apr 23, 2025 6:35am
Ypsomed manufacturing

Ypsomed sells diabetes business to focus on GLP-1 self-injectors

Apr 23, 2025 6:20am
More News

German cancer antibody biotech eyes SPAC as route to Nasdaq

Apr 23, 2025 6:09am

BD launches surgical monitor with AI blood pressure predictions

Apr 22, 2025 2:00pm

Biolinq raises $100M to carry glucose sensor patch to the FDA

Apr 22, 2025 12:00pm

Harvard sues Trump admin over threats to freeze research funds

Apr 22, 2025 10:54am